Current status of Clostridium difficile infection epidemiology
about
Microbiome mediation of infections in the cancer settingRecent advances in the understanding of antibiotic resistance in Clostridium difficile infectionLessons Learned in Antibiotic Stewardship: Fluoroquinolone Use in PediatricsFecal microbiota transplantation for the treatment of Clostridium difficile infectionWSES guidelines for management of Clostridium difficile infection in surgical patientsAcid suppression and the risk of Clostridium difficile infectionCurrent Trends in the Epidemiology and Outcomes of Clostridium difficile InfectionChemical and Stress Resistances of Clostridium difficile Spores and Vegetative CellsTreatment of Clostridium difficile infection using SQ641, a capuramycin analogue, increases post-treatment survival and improves clinical measures of disease in a murine model.Role of leptin-mediated colonic inflammation in defense against Clostridium difficile colitisUse of data envelopment analysis to quantify opportunities for antibacterial targets for reduction of health care-associated Clostridium difficile infection.Clostridium difficile bacteremia: Report of two cases in French hospitals and comprehensive review of the literature.Primary Outcomes From a Phase 3, Randomized, Double-Blind, Active-Controlled Trial of Surotomycin in Subjects With Clostridium difficile Infection.CAGS and ACS evidence based reviews in surgery. Is a diverting loop ileostomy and colonic lavage an alternative to colectomy for the treatment of severe Clostridium difficile-associated disease?Risk factors for Clostridium difficile infections - an overview of the evidence base and challenges in data synthesis.Efficacy and safety of ridinilazole compared with vancomycin for the treatment of Clostridium difficile infection: a phase 2, randomised, double-blind, active-controlled, non-inferiority study.Safety and tolerability of rifaximin for the treatment of irritable bowel syndrome without constipation: a pooled analysis of randomised, double-blind, placebo-controlled trials.Epidemiology of Clostridium difficile infectionRisks associated with the therapeutic use of fluoroquinolones.Investigational antimicrobial agents of 2013.Depression, antidepressant medications, and risk of Clostridium difficile infectionProgress in the discovery of treatments for C. difficile infection: A clinical and medicinal chemistry review.Microbiota transplantation restores normal fecal bile acid composition in recurrent Clostridium difficile infection.Epidemiology of Clostridium difficile infection among active duty United States military personnel (1998-2010).Proceedings of the 2013 A.S.P.E.N. Research workshop: the interface between nutrition and the gut microbiome: implications and applications for human health [corrected].The systemic inflammatory response to Clostridium difficile infectionEvaluation of portability and cost of a fluorescent PCR ribotyping protocol for Clostridium difficile epidemiology.High Mortality Risk in Chronic Kidney Disease and End Stage Kidney Disease Patients with Clostridium Difficile Infection: A Systematic Review and Meta-analysis.Media Discourse on the Social Acceptability of Fecal Transplants.Epidemiology and outcomes of community-acquired Clostridium difficile infections in Medicare beneficiariesImpact of Clostridium difficile infection among pneumonia and urinary tract infection hospitalizations: an analysis of the Nationwide Inpatient Sample.Changes in Colonic Bile Acid Composition following Fecal Microbiota Transplantation Are Sufficient to Control Clostridium difficile Germination and Growth.An Economic Analysis of Strategies to Control Clostridium Difficile Transmission and Infection Using an Agent-Based Simulation Model.Chronic kidney disease and end-stage renal disease are risk factors for poor outcomes of Clostridium difficile infection: a systematic review and meta-analysis.Rifaximin for the treatment of irritable bowel syndrome - a drug safety evaluation.Adverse Event Reporting for Proton Pump Inhibitor Therapy: An Overview of Systematic Reviews.Clostridium difficile ribotype 027: relationship to age, detectability of toxins A or B in stool with rapid testing, severe infection, and mortalityUnderstanding the mechanisms of faecal microbiota transplantation.Correlation between fecal calprotectin levels, disease severity and the hypervirulent ribotype 027 strain in patients with Clostridium difficile infectionRisk Factors for Community-associated Clostridium difficile-associated Diarrhea in Children.
P2860
Q26752672-7C3467B7-2765-4989-8C1F-D243C665A911Q26767079-33C2C4C1-4B04-4FC8-91D8-444FD3CB96F8Q26781072-EBE4D7C3-D05C-4F0B-97EB-E186CE137083Q26783516-9F5865AB-D674-4D4C-89F3-F0F149714700Q26795429-BB70FB03-CAA2-4A06-9370-A743D9A9F489Q26823599-A454A6F3-3B92-4328-BBED-96B6AB4AE8ECQ26996462-4A0D21B0-12FF-4232-AE35-ACFE3F786CF8Q28821061-D2D97A0B-FD3F-4862-B183-BE0C1BC33D7CQ30277636-DB0B6A54-0A12-4E16-88A4-F811C5F079E5Q30412148-EBA6E85D-8581-4DC6-8874-62B23A912121Q30666603-F23AE604-5BA8-46B2-BD80-4A93F6202FEBQ33561562-5034AA91-E1CA-4612-A7F0-42F196A21FD8Q33629237-AB0FA167-1954-472F-B1F3-BA9C6044439EQ33671072-57D027D2-5359-4537-AA3E-635BE185132BQ33767958-0CDE7FF8-2422-4E93-B19F-81C962565F60Q33831557-CB9CDA89-5125-4827-B02B-917721F4E9FFQ33958376-D4ABCAB1-632F-4240-87D5-CA1D230314C3Q34027474-B40AEECE-D64B-4BEB-8C53-C2F698611B9FQ34343391-BB4B9FF5-3F9C-4C1F-A1B4-F65E1F423301Q34375204-786F8AB2-2FE1-40BE-9012-26FD64677078Q34707553-20F9CA9D-DB8D-4717-991A-60FEFC503CFFQ35044119-FFB2765D-95ED-4B91-8959-C465573169AFQ35055851-CD906ED3-3D34-4D63-8894-EB83232004A5Q35076928-92F7FBD5-E6B0-4894-8306-EC37F34E10A3Q35079014-A5586FA9-0695-4064-964B-A80B1EF026C4Q35124315-4574CF00-0890-445A-BA4B-33A5599722A6Q35193241-D2765EF1-B35E-471E-830C-6122C0E22862Q35383084-244694CC-6B53-4CAB-977F-3E46BB8495B9Q35543938-1A598BA7-4A15-45DB-A762-2A74EF796BF0Q35546417-4E68B25A-441C-4688-B3E9-A0C762A7D82EQ35678927-3B5B51B9-0292-4079-9F4B-1B33B15A3226Q35899010-C9CA189F-CC90-40B1-8470-052F4867AA0DQ35975135-A2709F4E-415D-446B-AFE8-C6CF39CAEB17Q36004544-666DC29C-812C-4566-BAEB-352E9F53B033Q36009729-791CF430-FBFF-46F4-B06F-4DC14BF2D509Q36020285-FAC1A5F2-88C5-41CE-B246-AA51B7C4EF04Q36049005-AA902560-ECC7-4457-9FEC-07F0DCF14B0CQ36058419-4F9E9120-6699-4D4F-A057-D1475119A25FQ36059395-5EF957E3-494C-4DB6-A5AF-5FF94B9AF12CQ36073202-B9A57263-D987-4DF4-B47F-76DAF835B6BF
P2860
Current status of Clostridium difficile infection epidemiology
description
2012 nî lūn-bûn
@nan
2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Current status of Clostridium difficile infection epidemiology
@ast
Current status of Clostridium difficile infection epidemiology
@en
Current status of Clostridium difficile infection epidemiology
@nl
type
label
Current status of Clostridium difficile infection epidemiology
@ast
Current status of Clostridium difficile infection epidemiology
@en
Current status of Clostridium difficile infection epidemiology
@nl
prefLabel
Current status of Clostridium difficile infection epidemiology
@ast
Current status of Clostridium difficile infection epidemiology
@en
Current status of Clostridium difficile infection epidemiology
@nl
P2093
P2860
P921
P356
P1476
Current status of Clostridium difficile infection epidemiology
@en
P2093
Carolyn V Gould
Fernanda C Lessa
L Clifford McDonald
P275
P2860
P304
P356
10.1093/CID/CIS319
P407
P478
55 Suppl 2
P577
2012-08-01T00:00:00Z